The Effects of the Process Cycling on Endothelial Integrity

28 day mortality, process cycle in group 21.9% versus the placebo group of 43.6%. 90 day mortality 31.7% versus 48.7% risk ratio of 0.65,. Days alive and free renal replacement therapy of 28 days compared to 21 days; a sofa score of 5.7 versus 6.7, p-value of 7.7, and 7 days 2.4 versus 12.8. So yes, we were very pleased. The second reaction comes from all consistent with the primary outcome. It's an effect that could be prolonged in some patients.